You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 018651


✉ Email this page to a colleague

« Back to Dashboard


NDA 018651 describes MARINOL, which is a drug marketed by Alkem Labs Ltd and is included in one NDA. It is available from four suppliers. Additional details are available on the MARINOL profile page.

The generic ingredient in MARINOL is dronabinol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
Summary for 018651
Tradename:MARINOL
Applicant:Alkem Labs Ltd
Ingredient:dronabinol
Patents:0
Pharmacology for NDA: 018651
Medical Subject Heading (MeSH) Categories for 018651
Suppliers and Packaging for NDA: 018651
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MARINOL dronabinol CAPSULE;ORAL 018651 NDA AUTHORIZED GENERIC Major Pharmaceuticals 0904-7144 0904-7144-61 100 BLISTER PACK in 1 CARTON (0904-7144-61) / 1 CAPSULE in 1 BLISTER PACK
MARINOL dronabinol CAPSULE;ORAL 018651 NDA AUTHORIZED GENERIC Major Pharmaceuticals 0904-7145 0904-7145-04 30 BLISTER PACK in 1 CARTON (0904-7145-04) / 1 CAPSULE in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2.5MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Expired US Patents for NDA 018651

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.